Materna Medical Raises $5M in B3 Financing led by InnovaHealth Partners

The company plans to use the funding to complete the EASE pivotal trial, expand access to the Milli® platform ahead of the expected launch of the Ellora™ Obstetrical System, increase manufacturing capacity, prepare for the commercial launch of Ellora, and strengthen market access as its new reimbursement code is now active.

With this funding, Materna is well positioned to complete pre-commercial activities and prepare for the launch of the Ellora Obstetrical System, supporting its mission to improve womens pelvic health outcomes.

Read More:Aligned Raises $60M in Series B Funding Led by PeakSpan Capital

“The company continues to achieve key milestones consistently, and we are energized by the strong ongoing support from our investors as we advance toward commercialization,” said Ariella P. Golomb, MD, Chair of the Board of Directors.

“We are thrilled to be entering this next phase as we prepare for the Ellora launch, bringing an important innovation to women’s health,” added Tracy MacNeal, President and CEO of Materna Medical.

About Materna Medical

Founded in 2010, Materna Medical is a women's health medical technology company headquartered in Mountain View, California. The company develops innovative solutions for unmet needs in obstetrics and gynecology, with a focus on improving pelvic health. Materna brings together engineers, scientists, researchers, and commercial experts to develop new technologies that improve the standard of care and help women protect their pelvic health.

Read More:Appnigma AI Closes Pre-Seed Funding Round Led by BetaBoom